Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis | stella

Learn Data Labs About Find trials matched to me

About Learn Data Labs Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis | stella

Back to Rheumatoid Arthritis trials

Recruiting

Plain-English translation of NCT07632846 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Read our Rheumatoid Arthritis research guide →

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

Egypt

Faculty of Pharmacy, Horus University in Egypt, Al Mansurah

Key details

Phase

Testing effectiveness

Sponsor

Horus University

Enrollment target

~50 participants

Started

May 2026

Primary completion

October 2026

Age range

18 Years – 60 Years

Last updated on clinicaltrials.gov in June 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Amira Mashaly

Horus University

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.